Versant Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Versant Capital Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$684K	Buy	42,686 +4,169	+11%	+$69K	0.06%	201
2026 Q1	$713K	Buy	38,517 +3,534	+10%	+$62K	0.07%	188
2025 Q4	$545K	Buy	34,983 +7,913	+29%	+$113K	0.07%	204
2025 Q3	$396K	Buy	27,070 +2,074	+8%	+$30.8K	0.05%	263
2025 Q2	$386K	Sell	24,996 -134	-0.5%	-$1.98K	0.06%	241
2025 Q1	$374K	Buy	25,130 +23,166	+1,180%	+$325K	0.06%	227
2024 Q4	$26K	Buy	+1,964	New	+$27K	0.01%	893
2019 Q2	–	Sell	-10	Closed	–	–	1679
2019 Q1	$0	Buy	+10	New	+$201	﹤0.01%	1725

Other funds holding TAK

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

BSW Wealth Partners Boulder, Colorado $899M AUM 28.56% 1-Year Est. Return

Fulton Bank Lancaster, Pennsylvania $3.27B AUM 17.38% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Five Oceans Advisors Santa Monica, California $311M AUM 27.35% 1-Year Est. Return

Arista Wealth Management Las Vegas, Nevada $927M AUM 24.58% 1-Year Est. Return